Top 4 Mid-Cap Stocks In The Drugs-Generic Industry With The Highest ROA

Below are the top mid-cap drugs-generic stocks on the NYSE and the NASDAQ in terms of return on assets. The trailing-twelve-month return on assets at Akorn AKRX is 13.00%. Akorn's EPS for the same period is $0.46. The trailing-twelve-month return on assets at Salix Pharmaceuticals SLXP is 6.40%. Salix's revenue for the same period is $1.12 billion. The trailing-twelve-month return on assets at Mallinckrodt plc MNK is 2.50%. Mallinckrodt's operating margin for the same period is 9.20%. The trailing-twelve-month return on assets at Hospira HSP is 1.00%. Hospira's PEG ratio is 5.78.